Litcius/Paper detail

Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK)

Shankar Siva, Rohann Correa, Andrew Warner, Michael Staehler, Rodney J. Ellis, Lee Ponsky, Irving Kaplan, Anand Mahadevan, William Chu, Senthilkumar Gandhidasan, Anand Swaminath, Hiroshi Onishi, Bin S. Teh, Simon S. Lo, Alexander Muacevic, Alexander V. Louie

2020International Journal of Radiation Oncology*Biology*Physics78 citationsDOI

Topics & Concepts

MedicineRenal cell carcinomaRenal functionSABR volatility modelUrologyRadiosurgeryKidney cancerCohortProportional hazards modelInternal medicineOncologyNephrectomyRadiation therapyKidneyVolatility (finance)EconomicsFinancial economicsStochastic volatilityRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsHepatocellular Carcinoma Treatment and Prognosis
Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK) | Litcius